Worldwide, there is a growing appeal in the pharmaceutical industry for recombinant technologies that help alleviate, and eventually replace, the use of animal resources for endotoxin testing purposes. Adoption of recombinant test methods, like the PyroGene® rFC Assay, are on the rise. Increased use of recombinant methods has proven their equivalency to LAL-based methods and, therefore, increased confidence in implementing rFC methods in QC testing labs.
With the recombinant Factor C Assay, you can meet the demands of endotoxin testing while protecting a natural resource.
For a detailed product overview, educational materials, and scientific data about the effectiveness of rFC as a BET assay, please visit the PyroGene® rFC Product Page.
At Lonza, they are committed to protecting the welfare of the horseshoe crab through adopting best practices and actively supporting conservation efforts. To learn more about Lonza’s horseshoe crab conservation efforts please visit the Horseshoe Crab Conservation Page.